News | June 24, 2024
AstraZeneca Pharma India updates on exploring contract manufacturer
The company will now explore a buyer for its manufacturing site and exit in due course
The company will now explore a buyer for its manufacturing site and exit in due course
The USFDA has issued 15 observations pursuant to the completion of audit. JHSGP will submit an action plan on the observations
KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE
Contracts are related to a $487 million biotech expansion project in Denmark and first phase of a new life sciences production facility valued at $574 million in Central U.S.
The agreement extends the customer's suite of cloud DevOps, data engineering, and data platform management solutions
The US FDA in its communication mentioned it may withhold approval of any pending applications or supplements in which this facility is listed.
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
The plant, to be built in the Incheon Free Economic Zone in Songdo, Incheon, will be a facility for the manufacture of products such as sterile bags, cell culture media and membrane filters
Fredun received one-year contract worth Rs. 65 crores from a Southeast Asian country for Pharma exports
The company will provide free Diagnostics Service- X-ray Tele Radiology Services in District Hospitals / Sub-district Hospitals / Community Health Centers in the State of Tripura.
Subscribe To Our Newsletter & Stay Updated
